The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Yves-Alain Barde sits on this spectrum.
This scientist: 195 publications — 61st percentile
61% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Yves-Alain Barde sits on this spectrum.
This scientist: 91 D-Index — 89th percentile
89% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Yves-Alain Barde is affiliated with Cardiff University in the United Kingdom. Their research focuses primarily on Neuroscience, with extensive contributions to the subfields of Cellular and Molecular Neuroscience, Developmental Neuroscience, Molecular Biology, Genetics, and Cognitive Neuroscience.
Their scientific work has addressed key topics including nerve injury and regeneration, neurogenesis and neuroplasticity mechanisms, Autism Spectrum Disorder research, RNA interference and gene delivery, signaling pathways in disease, multiple sclerosis research studies, and polyomavirus-related diseases.
Coauthors frequently collaborating with Yves-Alain Barde include Sarah Ateaque, Fumie Akutsu, Shiro Sugino, Mitsuo Watanabe, and Masaaki Kojima.
Their recent publications demonstrate a consistent engagement with both clinical and molecular aspects of neuroscience. Notable papers are:
The preferred journals for publishing research include F1000Research, Frontiers in Molecular Neuroscience, Annals of Clinical and Translational Neurology, Orphanet Journal of Rare Diseases, and Journal of Neurochemistry.
Yves-Alain Barde has been recognized with several honors. They were elected a Member of Academia Europaea in 1995 and a Fellow of the Royal Society in the United Kingdom in 2017. They are also a Member of the European Molecular Biology Organization (EMBO).
Y.A. Barde;D. Edgar;H. Thoenen
Gary R. Lewin;Yves-Alain Barde
Yves-Alain Barde
H Thoenen;Y A Barde
Joachim Leibrock;Friedrich Lottspeich;Andreas Hohn;Magdalena Hofer
Carolyn Hyman;Magdalena Hofer;Yves-Alain Barde;Melissa Juhasz
Andreas Hohn;Joachim Leibrock;Karen Bailey;Yves-Alain Barde
Miriam Bibel;Yves-Alain Barde
M. Hofer;S. R. Pagliusi;A. Hohn;J. Leibrock
Lisa Schnell;Regula Schneider;Roland Kolbeck;Yves-Alain Barde
José María Frade;Alfredo Rodríguez-Tébar;Yves-Alain Barde
Nico Heins;Paolo Malatesta;Francesco Cecconi;Masato Nakafuku
Ralph F. Alderson;Andrea L. Alterman;Yves-Alain Barde;Ronald M. Lindsay
M Sendtner;B Holtmann;R Kolbeck;H Thoenen
Bruce D. Carter;Christian Kaltschmidt;Barbara Kaltschmidt;Nina Offenhäuser
Cathy Andorfer;Yvonne Kress;Marisol Espinoza;Rohan De Silva
Alfredo Rodriguez-Tebar;Georg Dechant;Yves-Alain Barde
Georg Dechant;Yves-Alain Barde
JE Johnson;YA Barde;M Schwab;H Thoenen
Toshihide Yamashita;Kerry Lee Tucker;Yves-Alain Barde
If you think any of the details on this page are incorrect, let us know.
Nankai University
La Trobe University
University of Pavia
Kyoto University
Chinese Academy of Sciences
University of Arizona
University of Alberta
University of Ottawa
University of Miami
University of Glasgow
Hiroshima University
University of Illinois at Chicago
Imperial College London
Nagoya Institute of Technology
Purdue University West Lafayette
Swedish University of Agricultural Sciences
